<DOC>
	<DOC>NCT00749385</DOC>
	<brief_summary>A pharmacokinetic study evaluating naproxen and esomeprazole blood levels in 4 treatments, each containing one or both components.</brief_summary>
	<brief_title>A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels</brief_title>
	<detailed_description>This study is being conducted to assess the relative bioavailability of naproxen and esomeprazole from a single dose of PN 400 (delayed-release naproxen 500mg / immediate-release esomeprazole 20mg), enteric-coated naproxen 500mg co-administered with enteric-coated esomeprazole 20mg, enteric-coated naproxen 500mg administered alone, and enteric-coated esomeprazole 20mg administered alone.</detailed_description>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Healthy males and nonpregnant, nonlactating females who are either of nonchildbearing potential or using an acceptable method of birth control. Standard exclusion criteria for a study of this nature no significant medical conditions that might affect the interpretation of the PK data or compromise the safety of the subject.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>